Invest now
Tatva Chintan Pharma Chem share price
High risk
You have to be logged in to add this to Watchlist.- ₹1,700.00(-2.06%)August 7, 2026 15:29:46 PM IST
- NSE
- BSE
- Vol : 85.59 K (NSE + BSE)Last 20 day avg : 392.98 K
Tatva Chintan Pharma Chem is trading -2.06% lower at Rs 1,700.00 as compared to its last closing price. Tatva Chintan Pharma Chem has been trading in the price range of 1,769.70 & 1,681.00. Tatva Chintan Pharma Chem has given 28.83% in this year & -3.88% in the last 5 days. Tatva Chintan Pharma Chem has TTM P/E ratio 54.36 as compared to the sector P/E of 28.18.There are 5 analysts who have initiated coverage on Tatva Chintan Pharma Chem. There are 2 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 15.98 Crores in its last quarter.Listed peers of Tatva Chintan Pharma Chem include Asian Paints (-1.02%), Solar Industries India (-0.86%), Pidilite Industries (-0.54%).The Mutual Fund holding in Tatva Chintan Pharma Chem was at 2.79% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Tatva Chintan Pharma Chem was at 3.93% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 10 Aug 2026, 07:02 AM IST
- BetaHigh volatility1.38Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.15The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.12Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-18.27The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Tatva Chintan Pharma Chem News
Tatva Chintan Pharma Chem Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Asian Paints | 2,721.00 | -1.02 | 2,60,997.72 | 58.09 | 12.06 | 1.02 | 11.95 |
| Solar Industries India | 18,400.00 | -0.86 | 1,66,501.70 | 99.61 | 26.62 | 0.06 | 13.68 |
| Pidilite Industries | 1,662.00 | -0.54 | 1,69,156.76 | 64.76 | 14.71 | 0.73 | 2.03 |
| SRF | 2,616.50 | -0.36 | 77,559.56 | 44.57 | 6.07 | 0.31 | 14.26 |
| Linde India | 7,085.00 | -0.76 | 60,717.27 | 110.53 | 14.22 | 0.06 | 1.76 |
Mutual Fund Ownership
View allTatva Chintan Pharma Chem Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-17 | Quarterly Results |
| 2026-05-16 | Audited Results & Final Dividend |
| 2026-01-21 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-24 | Quarterly Results |
About the company Tatva Chintan Pharma Chem
- IndustryChemical Manufacturing
- ISININE0GK401011
- BSE Code543321
- NSE CodeTATVA
Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is primarily engaged in manufacturing, sale and distribution of specialty chemicals, phase transfer catalysts (PTC), structure directing agents (SDA), electrolyte salts and solutions (ESS), pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). It operates in the Specialty chemical segment. Its SDA is a high purity quaternary salt, which plays a role in forming channels during the synthesis of zeolites. PTC acts as a catalyst in chemical reactions, facilitating reactions between reactants of different phases. Its products serve various sectors, including automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India.
Tatva Chintan Pharma Chem Share Price FAQs
Tatva Chintan Pharma Chem is trading at 1700.00 as on Fri Aug 07 2026 09:59:46. This is -2.06% lower as compared to its previous closing price of 1735.75.
The market capitalization of Tatva Chintan Pharma Chem is 4041.26 Cr as on Fri Aug 07 2026 09:59:46.
The average broker rating on Tatva Chintan Pharma Chem is Hold. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 1 analysts have given a hold rating
- 1 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Tatva Chintan Pharma Chem is 1838.85 whereas the 52 wk low is 977.85
Tatva Chintan Pharma Chem can be analyzed on the following key metrics -
- TTM P/E: 54.36
- Sector P/E: 28.18
- Dividend Yield: 0.12%
- D/E ratio: -
Tatva Chintan Pharma Chem reported a net profit of 42.05 Cr in 2026.
The Mutual Fund Shareholding was 2.79% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Tatva Chintan Pharma Chem QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.